2Haddad PM. Antipsychotic - induced hyperprolactinaemia: mechanisms, clinical features and management. Drugs, 2004; 64:2291-2314.
3Bushe C, Shaw M. Prevalence of hyperprolactinaemi a in a naturalistic cohort of schizophrenia and bipolar outpatients during treatment with typical and atypical antipsychotics. J Psychopharmacol.2007 ; 21 (7) : 768-773.
4Bushe C. Prevalence of hyperprolactinaemia in a naturalistic cohort of schizophrenia and bipolar outpatients during treat- ment with typical and atypical antipsychotics. J Psychophar- macol.2007 ; 21 : 768-773.
5Robert W, Kerwin L, Horwas K, et al. A multicentre ran- domized naturalistic open- label study between aripiprazole and standard of care in the management of community-treated schizophrenic patients Schizo- phrenia Trial of Aripiprazole: (START) study. European Psychiatry, 2007 ;22:433-443.
